137 related articles for article (PubMed ID: 11925752)
1. [Cloning of the human cytochrome p450 2B6 gene in Escherichia coli cells].
Kolomeĭchuk SN; Pokrovskaia MV; Borisova AA; Zhgun AA; Solodar' LI; Sokolov NN; Shvets VI; Gervaziev IuV; El'darov MA; Archakov AI
Vopr Med Khim; 2001; 47(6):609-19. PubMed ID: 11925752
[TBL] [Abstract][Full Text] [Related]
2. Expression of human cytochrome P450 2B6 in Escherichia coli: characterization of catalytic activity and expression levels in human liver.
Hanna IH; Reed JR; Guengerich FP; Hollenberg PF
Arch Biochem Biophys; 2000 Apr; 376(1):206-16. PubMed ID: 10729207
[TBL] [Abstract][Full Text] [Related]
3. Human CYP2B6: expression, inducibility and catalytic activities.
Gervot L; Rochat B; Gautier JC; Bohnenstengel F; Kroemer H; de Berardinis V; Martin H; Beaune P; de Waziers I
Pharmacogenetics; 1999 Jun; 9(3):295-306. PubMed ID: 10471061
[TBL] [Abstract][Full Text] [Related]
4. Regulation of CYP3A9 gene expression by estrogen and catalytic studies using cytochrome P450 3A9 expressed in Escherichia coli.
Wang H; Strobel HW
Arch Biochem Biophys; 1997 Aug; 344(2):365-72. PubMed ID: 9264551
[TBL] [Abstract][Full Text] [Related]
5. Validation of bupropion hydroxylation as a selective marker of human cytochrome P450 2B6 catalytic activity.
Faucette SR; Hawke RL; Lecluyse EL; Shord SS; Yan B; Laethem RM; Lindley CM
Drug Metab Dispos; 2000 Oct; 28(10):1222-30. PubMed ID: 10997944
[TBL] [Abstract][Full Text] [Related]
6. Human cytochrome P4502B6: interindividual hepatic expression, substrate specificity, and role in procarcinogen activation.
Code EL; Crespi CL; Penman BW; Gonzalez FJ; Chang TK; Waxman DJ
Drug Metab Dispos; 1997 Aug; 25(8):985-93. PubMed ID: 9280407
[TBL] [Abstract][Full Text] [Related]
7. Structure-function analysis of human cytochrome P-450 2B6 using a novel substrate, site-directed mutagenesis, and molecular modeling.
Domanski TL; Schultz KM; Roussel F; Stevens JC; Halpert JR
J Pharmacol Exp Ther; 1999 Sep; 290(3):1141-7. PubMed ID: 10454488
[TBL] [Abstract][Full Text] [Related]
8. Subcellular localization, aggregation state, and catalytic activity of microsomal P450 cytochromes modified in the NH2-terminal region and expressed in Escherichia coli.
Pernecky SJ; Olken NM; Bestervelt LL; Coon MJ
Arch Biochem Biophys; 1995 Apr; 318(2):446-56. PubMed ID: 7733676
[TBL] [Abstract][Full Text] [Related]
9. Coexpression of mammalian cytochrome P450 and reductase in Escherichia coli.
Dong J; Porter TD
Arch Biochem Biophys; 1996 Mar; 327(2):254-9. PubMed ID: 8619611
[TBL] [Abstract][Full Text] [Related]
10. A truncation of 2B subfamily cytochromes P450 yields increased expression levels, increased solubility, and decreased aggregation while retaining function.
Scott EE; Spatzenegger M; Halpert JR
Arch Biochem Biophys; 2001 Nov; 395(1):57-68. PubMed ID: 11673866
[TBL] [Abstract][Full Text] [Related]
11. Investigation of the mechanisms underlying the differential effects of the K262R mutation of P450 2B6 on catalytic activity.
Bumpus NN; Hollenberg PF
Mol Pharmacol; 2008 Oct; 74(4):990-9. PubMed ID: 18621926
[TBL] [Abstract][Full Text] [Related]
12. Purification and characterization of recombinant-expressed cytochrome P450 2C3 from Escherichia coli: 2C3 encodes the 6 beta-hydroxylase deficient form of P450 3b.
Richardson TH; Hsu MH; Kronbach T; Barnes HJ; Chan G; Waterman MR; Kemper B; Johnson EF
Arch Biochem Biophys; 1993 Jan; 300(1):510-6. PubMed ID: 8380971
[TBL] [Abstract][Full Text] [Related]
13. Importance of amino acid residue 474 for substrate specificity of canine and human cytochrome p450 3A enzymes.
He YQ; Roussel F; Halpert JR
Arch Biochem Biophys; 2001 May; 389(2):264-70. PubMed ID: 11339816
[TBL] [Abstract][Full Text] [Related]
14. Decreased susceptibility of the cytochrome P450 2B6 variant K262R to inhibition by several clinically important drugs.
Talakad JC; Kumar S; Halpert JR
Drug Metab Dispos; 2009 Mar; 37(3):644-50. PubMed ID: 19074527
[TBL] [Abstract][Full Text] [Related]
15. Overexpression and purification of the membrane-bound cytochrome P450 2B4.
Saribas AS; Gruenke L; Waskell L
Protein Expr Purif; 2001 Mar; 21(2):303-9. PubMed ID: 11237692
[TBL] [Abstract][Full Text] [Related]
16. Cloning, sequencing, heterologous expression, and characterization of murine cytochrome P450 3a25*(Cyp3a25), a testosterone 6beta-hydroxylase.
Dai D; Bai R; Hodgson E; Rose RL
J Biochem Mol Toxicol; 2001; 15(2):90-9. PubMed ID: 11284050
[TBL] [Abstract][Full Text] [Related]
17. The role of CYP2B6 in human xenobiotic metabolism.
Ekins S; Wrighton SA
Drug Metab Rev; 1999 Aug; 31(3):719-54. PubMed ID: 10461547
[No Abstract] [Full Text] [Related]
18. Baculovirus expression of human P450 2E1 and cytochrome b5: spectral and catalytic properties and effect of b5 on the stoichiometry of P450 2E1-catalyzed reactions.
Patten CJ; Koch P
Arch Biochem Biophys; 1995 Mar; 317(2):504-13. PubMed ID: 7893169
[TBL] [Abstract][Full Text] [Related]
19. Improvement in the expression of CYP2B6 by co-expression with molecular chaperones GroES/EL in Escherichia coli.
Mitsuda M; Iwasaki M
Protein Expr Purif; 2006 Apr; 46(2):401-5. PubMed ID: 16310378
[TBL] [Abstract][Full Text] [Related]
20. Cloning and functional expression of a first inducible avian cytochrome P450 of the CYP3A subfamily (CYP3A37).
Ourlin JC; Baader M; Fraser D; Halpert JR; Meyer UA
Arch Biochem Biophys; 2000 Jan; 373(2):375-84. PubMed ID: 10620362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
